leucovorin calcium / Generic mfg. 
Welcome,         Profile    Billing    Logout  
 424 Diseases   807 Trials   807 Trials   14372 News 


«12...200201202203204205206207208209210...235236»
  • ||||||||||  leucovorin calcium / Generic mfg.
    Trial primary completion date:  A Folinic Acid Intervention for Autism Spectrum Disorders (clinicaltrials.gov) -  Apr 1, 2016   
    P2,  N=99, Terminated, 
    Not yet recruiting --> Recruiting | Initiation date: Dec 2015 --> Mar 2016 Trial primary completion date: Jun 2015 --> Nov 2015
  • ||||||||||  futuximab/modotuximab (S95026) / Servier
    Enrollment open, Combination therapy, Metastases:  Sym004 in Combination With FOLFIRI in Metastatic Colorectal Cancer Patients (clinicaltrials.gov) -  Mar 24, 2016   
    P1/2,  N=50, Recruiting, 
    N=64 --> 250 | Trial primary completion date: Jun 2016 --> Jun 2018 Not yet recruiting --> Recruiting
  • ||||||||||  TheraSphere (yttrium 90 microspheres) / Boston Scientific
    Trial completion:  Phase II Trial Evaluating OS With Therasphere (clinicaltrials.gov) -  Mar 18, 2016   
    P2,  N=9, Completed, 
    N=280 --> 380 Active, not recruiting --> Completed
  • ||||||||||  sapitinib (AZD8931) / AstraZeneca
    Trial primary completion date, Combination therapy:  PANTHER: Phase I/II Trial of Antagonism of HER in GI Cancer (clinicaltrials.gov) -  Mar 16, 2016   
    P1/2,  N=24, Recruiting, 
    Not yet recruiting --> Active, not recruiting Trial primary completion date: Feb 2016 --> Jun 2016
  • ||||||||||  LY2090314 / Eli Lilly
    Enrollment change, Trial termination, Trial primary completion date, Metastases, Biopsy:  A Study of LY2090314 and Chemotherapy in Participants With Metastatic Pancreatic Cancer (clinicaltrials.gov) -  Feb 26, 2016   
    P1/2,  N=13, Terminated, 
    Active, not recruiting --> Completed | Trial primary completion date: Aug 2016 --> Feb 2016 N=45 --> 13 | Active, not recruiting --> Terminated | Trial primary completion date: Dec 2019 --> Jun 2015; Study has been terminated due to slow enrollment.